Research Research groups Molecular therapies for neurometabolic and retinal diseases

About

We focus on developing RNA-based therapies and personalized human models, such as a retina-on-chip system, for rare neuro(sensory)metabolic diseases, with an emphasis on brain and retina-related conditions to evaluate these therapeutic strategies.


Research group leader

dr. Alex Garanto Iglesias PhD

contact form

Publications

See some of our most important scientific articles.

read more

Publications



Profile page

See the group leader's profile.

see page